FR2786M - Drug for the treatment of heart disease. - Google Patents

Drug for the treatment of heart disease.

Info

Publication number
FR2786M
FR2786M FR921896A FR921896A FR2786M FR 2786 M FR2786 M FR 2786M FR 921896 A FR921896 A FR 921896A FR 921896 A FR921896 A FR 921896A FR 2786 M FR2786 M FR 2786M
Authority
FR
France
Prior art keywords
drug
treatment
heart disease
heart
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR921896A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3759761A external-priority patent/GB1005021A/en
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of FR2786M publication Critical patent/FR2786M/en
Expired legal-status Critical Current

Links

FR921896A 1961-10-19 1963-01-18 Drug for the treatment of heart disease. Expired FR2786M (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB3759761A GB1005021A (en) 1961-10-19 1961-10-19 Naphthalene derivatives
GB3759961 1961-10-19
FR912859 1962-10-19

Publications (1)

Publication Number Publication Date
FR2786M true FR2786M (en) 1964-09-14

Family

ID=26263509

Family Applications (1)

Application Number Title Priority Date Filing Date
FR921896A Expired FR2786M (en) 1961-10-19 1963-01-18 Drug for the treatment of heart disease.

Country Status (2)

Country Link
DK (1) DK103130C (en)
FR (1) FR2786M (en)

Also Published As

Publication number Publication date
DK103130C (en) 1965-11-22

Similar Documents

Publication Publication Date Title
FR3010M (en) New drugs derived from benzene for the treatment of heart disease.
FR2489M (en) Drug for the treatment of amoebic dysentery.
FR2193M (en) New drug for the treatment of infectious diseases.
FR1056M (en) Pharmaceutical product intended for the treatment of circulatory disorders of the upper or lower limbs.
FR2786M (en) Drug for the treatment of heart disease.
FR1489M (en) 4,4 'substituted diphenlysulfones and pharmaceutical preparations thereof for the treatment of viral diseases.
FR2576M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR2264M (en) Preparation for the treatment of skin diseases.
FR1857M (en) New drug in particular for the treatment of diseases of viral origin.
BE614154A (en) New products for the treatment of cardiac arrhythmias.
BE598672A (en) Therapeutic composition for the treatment of hepatic disorders.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR363M (en) New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.
FR2817M (en) Combinations of drugs for the treatment of mental disorders.
FR1961M (en) Compositions for the treatment of drug addiction.
FR1224M (en) Homeoflora treatment of the sebaceous glands.
FR1039M (en) Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses.
FR3744M (en) Drugs for the treatment of psychiatric conditions.
FR32M (en) New drug 6b-ethyl deserpidic for the treatment of arterial hypertension.
FR2346M (en) Drug for the treatment of colopathies.
FR1282872A (en) Headdress for the treatment of the hair
BE591276A (en) Therapeutic compounds for the treatment of the skin.
FR2569M (en) Pharmaceutical compositions for the local treatment of tissues.
FR1596M (en) Drug for the treatment of alcoholism.
BE598665A (en) Pharmaceutical preparations for the treatment of leukemia.